Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2150835018 | Efalizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2158639014 | Efalizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Efalizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Efalizumab (substance) | Is a | Immunosuppressant (substance) | true | Inferred relationship | Some | ||
| Efalizumab (substance) | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Efalizumab (substance) | Has disposition (attribute) | Immunomodulator (disposition) | true | Inferred relationship | Some | ||
| Efalizumab (substance) | Is a | Murine-human monoclonal immunoglobulin G antibody | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing efalizumab (medicinal product) | Has active ingredient | True | Efalizumab (substance) | Inferred relationship | Some | 1 |
| Raptiva | Has active ingredient | False | Efalizumab (substance) | Inferred relationship | Some | |
| Efalizumab 125mg/vial lyophilized powder for injection | Has active ingredient | False | Efalizumab (substance) | Inferred relationship | Some | |
| Raptiva 125mg/vial lyophilized powder for injection | Has active ingredient | False | Efalizumab (substance) | Inferred relationship | Some | |
| Efalizumab only product | Has active ingredient | True | Efalizumab (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR